A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2006
12/13/2006	CN1878549A Percutaneous absorption type cerebral protective agent
12/13/2006	CN1878545A Thyroid hormone analogs and methods of use
12/13/2006	CN1878536A Antimicrobial compositions and methods
12/13/2006	CN1876657A Stabilization of macrolides
12/13/2006	CN1876187A Double-head radical lipid prodrug
12/13/2006	CN1876186A Endostatin conjugate and its preparation method
12/13/2006	CN1876185A Biodegradable hyaluronic acid derivative and composition containing micelles made therefom
12/13/2006	CN1876177A Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses
12/13/2006	CN1876040A Pharmaceutical composition for treating hepatitis, its preparation process and quality control method
12/13/2006	CN1875983A Oral liquid for preventing and treating avian coccidiosis and preparation method thereof
12/13/2006	CN1875973A A pharmaceutical composition containing N3-o-toluyl-fluorouracil and its liposome preparation
12/13/2006	CN1875965A A micro-emulsion containing Vitamin C and Vitamin E and preparation method thereof
12/13/2006	CN1875960A A nanoemulsion medicine of eugenol and preparation method thereof
12/13/2006	CN1875957A A nano antibacterial medicine of furacillin and preparation method thereof
12/13/2006	CN1875953A Percutaneous absorption-type pharmaceutical preparation
12/13/2006	CN1875952A Percutaneous absorption-type pharmaceutical preparation
12/13/2006	CN1875949A Soft gastrodine capsule and preparation method thereof
12/13/2006	CN1875948A Hollow cellulose capsule and preparation method thereof
12/13/2006	CN1875947A An oral preparation containing caderofloxacin lactate
12/13/2006	CN1875946A Nanoparticle of 10-hydroxycamtothecine and preparation method thereof
12/13/2006	CN1875944A A carbowax modified stealthy liposome nanosphere of hydroxycamtothecine and preparation method thereof
12/13/2006	CN1875943A Medicinal aerosol formulation
12/13/2006	CN1875941A An antibacterial rifampicin nanoemulsion and preparation method thereof
12/13/2006	CN1875940A Anticancer sustained release agent containing clorfarabine and its synergist
12/13/2006	CN1875939A A sustained release anticancer agent carrying angiogenesis inhibitor and clorfarabine
12/13/2006	CN1875938A A sustained release anticancer injection containing clorfarabine and its synergist
12/13/2006	CN1875937A A sustained release injection carrying clorfarabine and cytotoxic drug
12/13/2006	CN1875936A Anticancer sustained release agent containing clorfarabine and cytotoxic drug
12/13/2006	CN1875935A A sustained release anticancer agent containing clorfarabine and cytotoxic drug
12/13/2006	CN1875934A An anticancer sustained release injection carrying clorfarabine and its synergist
12/13/2006	CN1875933A Sustained release anticancer agent carrying angiogenesis inhibitor and cytotoxic drug
12/13/2006	CN1875932A A compound sustained release anticancer agent containing angiogenesis inhibitor
12/13/2006	CN1875931A An anticancer sustained release agent carrying angiogenesis inhibitor and cytotoxic drug
12/13/2006	CN1875930A An anticancer sustained release injection carrying tumor drug resistance reversal agent and cytotoxic drug simultaneously
12/13/2006	CN1875929A An anticancer sustained release injection carrying tumor drug resistance reversal agent and reversal agent synergist
12/13/2006	CN1875928A Anticancer sustained release injection containing tumor drug resistance reversal agent and cytotoxic drug
12/13/2006	CN1875927A Injection containing caderfloxacin lactate
12/13/2006	CN1875926A Injectable composition of clopidogrel and its salt and preparation method thereof
12/13/2006	CN1875925A Sodium tashinone II A sulfonate injection and preparation method thereof
12/13/2006	CN1875923A Compound closantel sodium-ivermectin injection for animal and preparation method thereof
12/13/2006	CN1875922A Compound ivermectin-albendazole injection for animal and preparation method thereof
12/13/2006	CN1289671C Antibody molecules having specificity for human tumor necrosis factory alpha, and use thereof
12/13/2006	CN1289573C Edible nanocore-shell colloid and its preparation method
12/13/2006	CN1289526C Stem cell factor
12/13/2006	CN1289517C Esters
12/13/2006	CN1289148C Carrier suitable for gene delivery and its preparation process
12/13/2006	CN1289088C Method for improving liposome enveloping rate of camptothecine or its derivatives
12/13/2006	CN1289081C Pharmaceutical composition for modified release insulin sensitiser
12/13/2006	CN1289076C Soluble stable pharmaceutical composition containing ritonavir and a process for the preparation of concentrated pharmaceutical compositions
12/13/2006	CN1289069C Pharmaceutical composition comprising a 5HT1 receptor agonist
12/13/2006	CN1289068C Solid formulation containing isomaltone itol and its preparation method
12/13/2006	CN1289067C Film forming composition containing 4,1,'6-tri-chloro-galacto-sucrose
12/13/2006	CN1289065C Vaccine containing saponin and sterol
12/13/2006	CN1289064C Drug delivery system
12/13/2006	CN1289063C Immune modulation device for use in animals
12/13/2006	CN1289059C Pre-formed sheet devices suitable for topical application
12/13/2006	CN1289058C Gel-form composition
12/12/2006	US7148350 Compounds in the form of homodimeric or heterodimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterases-mediated diseases or dysfunction
12/12/2006	US7148211 Improved water solubility; drug delivery; avoids irritation
12/12/2006	US7148207 For therapy of cancer; quick release tablet of fludarabine phosphate in a defined composition of residual contaminants
12/12/2006	US7148205 Intravascular delivery of non-viral nucleic acid
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7148199 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
12/12/2006	US7148190 Haptotactic peprides
12/12/2006	US7148038 Immunotherapy; antiproliferative agent
12/12/2006	US7148001 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of Alzheimer's and Prion diseases
12/12/2006	US7147917 Coating with water insoluble, amphipatic dispersants
12/12/2006	US7147874 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
12/12/2006	US7147873 I2 and/or an iodophor to provide an available iodine concentration of at least 0.25 wt-%; a hydroxycarboxylic acid buffer; water; and a substantive film-forming polymer.
12/12/2006	US7147869 Rapidly disintegrating tablet comprising an acid-labile active ingredient
12/12/2006	US7147859 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
12/12/2006	US7147858 Methods to improve immunogenicity of antigens and specificity of antibodies
12/12/2006	US7147850 Therapeutic binding agents against MUC-1 antigen and methods for their use
12/12/2006	US7147849 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity
12/12/2006	US7147845 Antimicrobial silver ion complex resinates
12/12/2006	US7147844 System for stabilizing lacrimal fluid layer
12/12/2006	CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006	CA2347741C Thiazole-derivatives
12/12/2006	CA2303339C A pharmaceutical composition for treating dysmenorrhea and premature labor
12/12/2006	CA2290531C Pharmaceutical formulation of omeprazole
12/12/2006	CA2242618C Compositions comprising ultrapure pvp having an average molecular weight in the range of 7,000 to 12,000 daltons
12/12/2006	CA2201598C Vaccine compositions
12/12/2006	CA2183331C Process for producing a sterile prednisolone gel
12/12/2006	CA2179294C Low molecular weight hyaluronic acid with peptide or protein
12/12/2006	CA2162670C High dose formulations of mycophenolate mofetil, mycophenolic acid and ranolazine
12/07/2006	WO2006130799A2 Bioconjugation reactions for acylating polyethlene glycol reagents
12/07/2006	WO2006130745A1 Macromolecular conjugates of bone morphogenetic protein-7
12/07/2006	WO2006129893A1 Injectable drug carrier comprising layered double hydroxide
12/07/2006	WO2006129788A1 Agent for regeneration and/or protection of nerves
12/07/2006	WO2006129745A1 Skin patch
12/07/2006	WO2006129668A1 Sugar-coated pill
12/07/2006	WO2006129594A1 Method for producing nucleic acid-containing complex preparation
12/07/2006	WO2006129468A1 Process for preparation of granular oral composition using oligosaccharide solution
12/07/2006	WO2006129386A1 Enteric medicinal composition for oral use
12/07/2006	WO2006129323A1 A composition to enhance the bioavailability of curcumin
12/07/2006	WO2006129167A1 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS
12/07/2006	WO2006129160A2 Stable aqueous oral solution of risperidone
12/07/2006	WO2006129127A1 Compositions comprising a lipid and copolymer of styrene and maleic acid
12/07/2006	WO2006129095A2 Sustained release preparations of pro-insulin c-peptide
12/07/2006	WO2006129080A1 Materials and methods for transducing cells with a viral vector

1 ... 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 ... 1712